Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
It’s not often that a company with the scale and…
Sell
43
CSWC Quote, Financials, Valuation and Earnings
Last price:
$20.76
Seasonality move
:
5.44%
Day range:
$20.68 - $21.25
52-week range:
$20.68 - $27.23
Dividend yield:
12.02%
P/E ratio:
12.84x
P/S ratio:
9.10x
P/B ratio:
1.27x
Volume:
1.1M
Avg. volume:
661.3K
1-year change:
-9.23%
Market cap:
$1B
Revenue:
$109.1M
EPS (TTM):
$1.64
| Period Ending | 2020-03-31 | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | -$236K | $72.6M | $83M | $61.5M | $109.1M | |
| Revenue Growth (YoY) | -- | -- | 14.37% | -25.96% | 77.47% | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $5.7M | $5.3M | $6.6M | $7.8M | $8.9M | |
| Other Inc / (Exp) | $45.7M | -$8.5M | $7.3M | -$16.9M | -$39.6M | |
| Operating Expenses | $15.9M | $17M | $36.2M | $21.4M | $24.5M | |
| Operating Income | -- | -- | -- | -- | -- | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | -$16.1M | $55.6M | $46.8M | $40.1M | $84.6M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $6.2M | $4.7M | $4M | $7M | $1.2M | |
| Net Income to Company | -$22.4M | $50.9M | $42.8M | $33.1M | $83.4M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$22.4M | $50.9M | $42.8M | $33.1M | $83.4M | |
| Basic EPS (Cont. Ops) | -$1.24 | $2.67 | $1.87 | $1.10 | $2.05 | |
| Diluted EPS (Cont. Ops) | -$1.24 | $2.67 | $1.87 | $1.10 | $2.05 | |
| Weighted Average Basic Share | $18M | $19.1M | $22.8M | $30M | $40.7M | |
| Weighted Average Diluted Share | $18M | $19.1M | $22.8M | $30M | $40.7M | |
| EBITDA | -- | -- | -- | -- | -- | |
| EBIT | -$309K | $73.5M | $66.8M | $68.9M | $127.7M | |
| Revenue (Reported) | -$236K | $72.6M | $83M | $61.5M | $109.1M | |
| Operating Income (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Adjusted) | -$309K | $73.5M | $66.8M | $68.9M | $127.7M | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | $21.4M | $18.7M | $16.6M | $27M | $27.6M | |
| Revenue Growth (YoY) | 170.82% | -12.39% | -11.34% | 62.52% | 2.41% | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $1.4M | $1.6M | $1.9M | $2.3M | $2.6M | |
| Other Inc / (Exp) | -$1.3M | $3.5M | -$8.7M | $362K | -$10.3M | |
| Operating Expenses | $4.5M | $21.9M | $5.2M | $6.2M | $6.1M | |
| Operating Income | -- | -- | -- | -- | -- | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | $16.9M | -$3.2M | $11.4M | $20.7M | $21.5M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $510K | $1.3M | $1.9M | -$1.9M | -$1.2M | |
| Net Income to Company | $16.4M | -$4.6M | $9.5M | $22.6M | $22.7M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $16.4M | -$4.6M | $9.5M | $22.6M | $22.7M | |
| Basic EPS (Cont. Ops) | $0.88 | -$0.20 | $0.34 | $0.57 | $0.48 | |
| Diluted EPS (Cont. Ops) | $0.88 | -$0.20 | $0.34 | $0.57 | $0.48 | |
| Weighted Average Basic Share | $18.6M | $22.5M | $28M | $39.7M | $47.2M | |
| Weighted Average Diluted Share | $18.6M | $22.5M | $28M | $39.7M | $47.2M | |
| EBITDA | -- | -- | -- | -- | -- | |
| EBIT | $21.3M | $2.2M | $18M | $31.2M | $34.1M | |
| Revenue (Reported) | $21.4M | $18.7M | $16.6M | $27M | $27.6M | |
| Operating Income (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Adjusted) | $21.3M | $2.2M | $18M | $31.2M | $34.1M | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | $15.1M | $76.7M | $69.2M | $93.7M | $103.2M | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $5.3M | $5.9M | $7.2M | $8.4M | $9.9M | |
| Other Inc / (Exp) | $37.4M | $834K | -$1.4M | -$22.8M | -$37.1M | |
| Operating Expenses | $15.6M | $35M | $19.7M | $23.7M | $26.3M | |
| Operating Income | -- | -- | -- | -- | -- | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | -$484K | $41.7M | $49.5M | $70M | $77M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $6M | $5.5M | $5.3M | $2.4M | $3.3M | |
| Net Income to Company | -$6.5M | $36.2M | $44.2M | $67.6M | $73.7M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$6.5M | $36.2M | $44.2M | $67.6M | $73.7M | |
| Basic EPS (Cont. Ops) | -$0.40 | $1.80 | $1.82 | $1.86 | $1.64 | |
| Diluted EPS (Cont. Ops) | -$0.40 | $1.80 | $1.82 | $1.86 | $1.64 | |
| Weighted Average Basic Share | -- | -- | -- | -- | -- | |
| Weighted Average Diluted Share | -- | -- | -- | -- | -- | |
| EBITDA | -- | -- | -- | -- | -- | |
| EBIT | $16.6M | $61.2M | $71.2M | $106.9M | $124.9M | |
| Revenue (Reported) | $15.1M | $76.7M | $69.2M | $93.7M | $103.2M | |
| Operating Income (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Adjusted) | $16.6M | $61.2M | $71.2M | $106.9M | $124.9M | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | $34.8M | $38.9M | $25.1M | $57.3M | $51.4M | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $2.7M | $3.3M | $3.9M | $4.5M | $5.5M | |
| Other Inc / (Exp) | -$6.8M | $2.5M | -$6.2M | -$12.1M | -$9.6M | |
| Operating Expenses | $8.1M | $26.1M | $9.6M | $11.9M | $13.7M | |
| Operating Income | -- | -- | -- | -- | -- | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | $26.7M | $12.8M | $15.4M | $45.3M | $37.7M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $1.4M | $2.2M | $3.5M | -$1.1M | $987K | |
| Net Income to Company | $25.3M | $10.6M | $12M | $46.4M | $36.7M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $25.3M | $10.6M | $12M | $46.4M | $36.7M | |
| Basic EPS (Cont. Ops) | $1.37 | $0.51 | $0.44 | $1.20 | $0.79 | |
| Diluted EPS (Cont. Ops) | $1.37 | $0.51 | $0.44 | $1.20 | $0.79 | |
| Weighted Average Basic Share | $36.7M | $43.7M | $53.5M | $77.3M | $92.9M | |
| Weighted Average Diluted Share | $36.7M | $43.7M | $53.5M | $77.3M | $92.9M | |
| EBITDA | -- | -- | -- | -- | -- | |
| EBIT | $35.4M | $23.1M | $27.5M | $65.5M | $62.7M | |
| Revenue (Reported) | $34.8M | $38.9M | $25.1M | $57.3M | $51.4M | |
| Operating Income (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Adjusted) | $35.4M | $23.1M | $27.5M | $65.5M | $62.7M | |
| Period Ending | 2020-03-31 | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $13.7M | $31.6M | $11.4M | $21.6M | $32.3M | |
| Short Term Investments | -- | -- | -- | -- | -- | |
| Accounts Receivable, Net | -- | -- | -- | -- | -- | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | -- | -- | -- | -- | -- | |
| Total Current Assets | $24.2M | $42.3M | $25.8M | $40.7M | $62.5M | |
| Property Plant And Equipment | -- | -- | -- | -- | -- | |
| Long-Term Investments | $553.1M | $688.4M | $936.6M | $1.2B | $1.5B | |
| Goodwill | -- | -- | -- | -- | -- | |
| Other Intangibles | -- | -- | -- | -- | -- | |
| Other Long-Term Assets | -- | -- | -- | -- | -- | |
| Total Assets | $585M | $735.6M | $974M | $1.3B | $1.6B | |
| Accounts Payable | -- | -- | -- | -- | -- | |
| Accrued Expenses | -- | -- | -- | -- | -- | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | $513K | $50K | $1.2M | $156K | $281K | |
| Long-Term Debt | -- | -- | -- | -- | -- | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $312.7M | $399.3M | $553.1M | $667.3M | $801.1M | |
| Common Stock | $5.1M | $5.8M | $6.8M | $9.6M | $11.3M | |
| Other Common Equity Adj | -- | -- | -- | -- | -- | |
| Common Equity | $272.2M | $336.3M | $420.9M | $590.4M | $755.7M | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | $272.2M | $336.3M | $420.9M | $590.4M | $755.7M | |
| Total Liabilities and Equity | $585M | $735.6M | $974M | $1.3B | $1.6B | |
| Cash and Short Terms | $13.7M | $31.6M | $11.4M | $21.6M | $32.3M | |
| Total Debt | $303.3M | $381.3M | $528.6M | $637.6M | $770.9M | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $16M | $26.8M | $30.2M | $23M | $47.2M | |
| Short Term Investments | -- | -- | -- | -- | -- | |
| Accounts Receivable, Net | -- | -- | -- | -- | -- | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | -- | -- | -- | -- | -- | |
| Total Current Assets | $26.5M | $41.4M | $45.8M | $47.9M | $78.7M | |
| Property Plant And Equipment | -- | -- | -- | -- | -- | |
| Long-Term Investments | $631.2M | $818.2M | $1.1B | $1.4B | $1.5B | |
| Goodwill | -- | -- | -- | -- | -- | |
| Other Intangibles | -- | -- | -- | -- | -- | |
| Other Long-Term Assets | -- | -- | -- | -- | -- | |
| Total Assets | $664.3M | $866.8M | $1.1B | $1.4B | $1.6B | |
| Accounts Payable | -- | -- | -- | -- | -- | |
| Accrued Expenses | -- | -- | -- | -- | -- | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | $649K | $117K | $258K | $463K | $799K | |
| Long-Term Debt | -- | -- | -- | -- | -- | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $378.1M | $484.9M | $637.4M | $759.1M | $813.2M | |
| Common Stock | $5.2M | $6.4M | $7.8M | $10M | $11.9M | |
| Other Common Equity Adj | -- | -- | -- | -- | -- | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | $286.1M | $381.9M | $475.7M | $657.8M | $791.3M | |
| Total Liabilities and Equity | $664.3M | $866.8M | $1.1B | $1.4B | $1.6B | |
| Cash and Short Terms | $16M | $26.8M | $30.2M | $23M | $47.2M | |
| Total Debt | $366M | $467.5M | $603.3M | $732.7M | $785M | |
| Period Ending | 2020-03-31 | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$22.4M | $50.9M | $42.8M | $33.1M | $83.4M | |
| Depreciation & Amoritzation | $2.4M | $2M | $2.2M | $2.8M | $4.3M | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | -$80K | $222K | -$3.8M | -$4.7M | -$3.9M | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -$47.9M | -$68.3M | -$182.7M | -$227.1M | -$188.5M | |
| Capital Expenditures | -- | -- | $2M | $281K | $13K | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -- | -- | -$2M | -$281K | -$13K | |
| Dividends Paid (Ex Special Dividend) | -$50.3M | -$39.9M | -$58.6M | -$71.1M | -$102.9M | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $205.5M | $369.6M | $500.4M | $263.1M | $406.9M | |
| Long-Term Debt Repaid | -$119M | -$293.1M | -$355M | -$155M | -$275M | |
| Repurchase of Common Stock | -$9.2M | -- | -- | -- | -- | |
| Other Financing Activities | -$418K | -$239K | -$16.6M | -$1M | -$1.1M | |
| Cash From Financing | $51.8M | $86.1M | $164.5M | $237.5M | $199.2M | |
| Beginning Cash (CF) | $9.9M | $13.7M | $31.6M | $11.4M | $21.6M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $3.8M | $17.9M | -$20.2M | $10.2M | $10.7M | |
| Ending Cash (CF) | $13.7M | $31.6M | $11.4M | $21.6M | $32.3M | |
| Levered Free Cash Flow | -$47.9M | -$68.3M | -$184.7M | -$227.4M | -$188.5M | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $16.4M | -$4.6M | $9.5M | $22.6M | $22.7M | |
| Depreciation & Amoritzation | $499K | $585K | $677K | $1.2M | $1.3M | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | -$339K | $1.6M | $1.4M | -$4.2M | -$6.5M | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -$23.9M | -$3.5M | -$25.8M | -$48.8M | -$23.8M | |
| Capital Expenditures | -- | -- | -- | -- | $497K | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -- | -- | -- | -- | -$497K | |
| Dividends Paid (Ex Special Dividend) | -$9.5M | -$12.4M | -$14.3M | -$24.8M | -$30.5M | |
| Special Dividend Paid | $100K | $100K | -- | -- | -- | |
| Long-Term Debt Issued | $115M | $234.5M | $40M | $94.9M | $70M | |
| Long-Term Debt Repaid | -$80M | -$220M | -$15M | -$35M | -$21M | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -$15.2M | -- | -- | -- | |
| Cash From Financing | $24.9M | $13.8M | $37.2M | $50.5M | $38.3M | |
| Beginning Cash (CF) | $15M | $16.5M | $18.8M | $21.3M | $33.3M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $1M | $10.3M | $11.5M | $1.7M | $13.9M | |
| Ending Cash (CF) | $16M | $26.8M | $30.2M | $23M | $47.2M | |
| Levered Free Cash Flow | -$23.9M | -$3.5M | -$25.8M | -$48.8M | -$24.3M | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$6.5M | $36.2M | $44.2M | $67.6M | $73.7M | |
| Depreciation & Amoritzation | $2.1M | $2.1M | $2.5M | $3.4M | $5M | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | -$1.2M | -$3.6M | -$727K | -$10M | -$6.6M | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -$93.3M | -$125.2M | -$174.4M | -$236M | -$76.8M | |
| Capital Expenditures | -- | -- | $156K | $127K | $533K | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -- | -- | -$2.2M | -$127K | -$533K | |
| Dividends Paid (Ex Special Dividend) | -$51.7M | -$44.9M | -$65.6M | -$87.9M | -$115.3M | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $237.8M | $531.1M | $330M | $373.5M | $306.4M | |
| Long-Term Debt Repaid | -- | -$433.1M | -$195M | -$245M | -$256M | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -$372K | -$16M | -$1.5M | -$1.3M | -$2M | |
| Cash From Financing | $79.3M | $136.1M | $180M | $228.9M | $101.5M | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -$14M | $10.8M | $3.4M | -$7.2M | $24.2M | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | -$93.3M | -$125.2M | -$174.4M | -$236.1M | -$77.3M | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $25.3M | $10.6M | $12M | $46.4M | $36.7M | |
| Depreciation & Amoritzation | $952K | $1.1M | $1.3M | $1.9M | $2.6M | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | $265K | -$3.6M | -$541K | -$5.9M | -$8.6M | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -$46.8M | -$103.8M | -$95.6M | -$104.4M | $7.3M | |
| Capital Expenditures | -- | -- | $156K | $2K | $522K | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -- | -- | -$156K | -$2K | -$522K | |
| Dividends Paid (Ex Special Dividend) | -$19M | -$23.9M | -$30.9M | -$47.7M | -$60M | |
| Special Dividend Paid | $200K | $200K | $150K | -- | -- | |
| Long-Term Debt Issued | $143M | $304.5M | $134M | $244.5M | $144M | |
| Long-Term Debt Repaid | -$80M | -$220M | -$60M | -$150M | -$131M | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -$3K | -$15.7M | -$641K | -$926K | -$1.9M | |
| Cash From Financing | $49.1M | $99M | $114.5M | $105.9M | $8.2M | |
| Beginning Cash (CF) | $28.7M | $48.2M | $30.2M | $42.9M | $65.6M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $2.3M | -$4.8M | $18.8M | $1.4M | $15M | |
| Ending Cash (CF) | $31M | $43.4M | $49M | $44.3M | $80.5M | |
| Levered Free Cash Flow | -$46.8M | -$103.8M | -$95.7M | -$104.4M | $6.8M | |
Get CSWC Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
CSWC
Sector
P/E ratio
12.84x
12.02x
PEG ratio
2.31x
0.36x
P/B ratio
1.27x
1.05x
Price / LTM sales
9.10x
2.55x
Growth Metrics
CSWC
Sector
Revenue growth
2.41%
6.08%
Earnings growth
-15.79%
6.45%
Revenue (5-year growth)
17.41%
5.85%
Earnings forecast
$0.65
$0.56
Profitability
CSWC
Sector
Profitability FY 2024
--
$179.9M
Return on invested capital
4.98%
5.27%
Return on assets
4.88%
0.98%
Return on equity
9.95%
9.43%
Earnings Date
Last Earnings Date
Oct
28
Next Earnings Date
Jan
29
Estimated Next Earnings Date
Jan
27
Balance Sheet
CSWC
Sector
Total cash
$47.2M
$617M
Short term investments
--
$408.4M
Total assets
$1.6B
$4.5B
Long term debt
$785M
$270.8M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will Tyson Foods Stock Bounce Back?
Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…
Will Iovance Biotherapeutics Stock Bounce Back?
Iovance Biotherapeutics (NASDAQ:IOVA) is a fledgling pharmaceutical company that specializes…
Stock Ideas
Buy
64
Is AAPL Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 42x
Buy
52
Is NVDA Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 113x
Buy
55
Is MSFT Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 37x
Alerts
Buy
61
QMCO alert for Dec 23
Quantum [QMCO] is up 3.98% over the past day.
Sell
46
NUKK alert for Dec 23
Nukkleus [NUKK] is up 8.75% over the past day.
Sell
1
IIPR alert for Dec 23
Innovative Industrial Properties [IIPR] is down 3.58% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
